Search results for "Isobutyric acid"

showing 8 items of 8 documents

Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection

2019

Background and aims Chronic hepatitis C virus (HCV) infection increases the risk of incident chronic kidney disease (CKD) and progression to end-stage renal disease (ESRD). Previously available direct-acting antiviral regimens are not approved for patients with advanced CKD across all HCV genotypes. Methods EXPEDITION-5 is a phase 3 study to evaluate efficacy and safety of the fixed-dose combination of glecaprevir and pibrentasvir (G/P) for chronic HCV infection (genotype 1 through 6) in adults without cirrhosis or with compensated cirrhosis and with stage 3b, 4 or 5 CKD. Patients received approved duration of G/P according to HCV genotype, cirrhosis status and prior HCV treatment experienc…

AdultCyclopropaneshepatitis C virusmedicine.medical_specialtyAminoisobutyric AcidsPyrrolidinesCirrhosisProlineLactams Macrocyclicmedicine.medical_treatmentAntiviral Agents03 medical and health sciences0302 clinical medicineLeucineQuinoxalinesInternal medicineGenotypeHumansMedicineAdverse effectDialysisSulfonamidesdirect-acting antiviralpangenotypicHepatologychronic kidney disease; cirrhosis; direct-acting antiviral; hepatitis C virus; pangenotypicbusiness.industrycirrhosisGlecaprevirHepatitis C Chronicmedicine.diseasePibrentasvirDrug Combinations030220 oncology & carcinogenesisBronchitisBenzimidazoles030211 gastroenterology & hepatologybusinesschronic kidney diseaseKidney disease
researchProduct

Faldaprevir (BI 201335), BI 207127 and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results

2013

Background Faldaprevir (BI 201335) and deleobuvir (BI 207127) are direct-acting antiviral agents under development for the treatment of chronic HCV infection. This article describes the final results of the Phase Ib SOUND-C1 study that evaluated the interferon-free oral combination of faldaprevir, deleobuvir and ribavirin in 32 treatment-naive patients infected with HCV genotype 1. Methods Patients were randomized to receive deleobuvir 400 mg ( n=15) or 600 mg ( n=17) three times daily plus faldaprevir 120 mg once daily and weight-based ribavirin for 4 weeks. Interferon-free therapy was followed by response-guided faldaprevir plus pegylated interferon-α2a/ribavirin to week 24 or 48. Results…

Aminoisobutyric AcidsProline[SDV]Life Sciences [q-bio]610 Medicine & healthHepacivirusAntiviral AgentsDrug Administration SchedulePolyethylene GlycolsTherapy naive03 medical and health scienceschemistry.chemical_compound0302 clinical medicineHcv genotype 1LeucineRibavirinMedicine2736 Pharmacology (medical)Pharmacology (medical)Oral therapy030304 developmental biologyPharmacology0303 health sciencesbusiness.industryRibavirinDeleobuvirInterferon-alpha2725 Infectious DiseasesHepatitis C ChronicViral LoadVirologyRecombinant Proteins3. Good healthThiazolesInfectious DiseasesTreatment Outcome10219 Clinic for Gastroenterology and Hepatology3004 PharmacologychemistryAcrylatesFaldaprevirQuinolines030211 gastroenterology & hepatologyBenzimidazolesDrug Therapy CombinationbusinessOligopeptides
researchProduct

Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1–6 Hepatitis C Virus Infections and Compensated Liver Disease

2019

Background: Untreated, chronic hepatitis C virus (HCV) infection may lead to progressive liver damage, which can be mitigated by successful treatment. This integrated analysis reports the safety, efficacy, and pharmacokinetics (PK) of the ribavirin-free, direct-acting, antiviral, fixed-dose combination of glecaprevir/pibrentasvir (G/P) in patients with chronic HCV genotype 1-6 infections and compensated liver disease, including patients with chronic kidney disease stages 4 or 5 (CKD 4/5). Methods: Data from 9 Phase II and III clinical trials, assessing the efficacy and safety of G/P treatment for 8-16 weeks, were included. The presence of cirrhosis was determined at screening using a liver …

CyclopropanesLiver CirrhosisMaleAminoisobutyric AcidsPyrrolidinesCirrhosisSustained Virologic Responseadverse eventHepacivirusmedicine.disease_causeGastroenterology0302 clinical medicine030212 general & internal medicinePathologie maladies infectieusesSulfonamidesmedicine.diagnostic_testLiver DiseasesPibrentasvirMicrobiologie et protistologie [entomologiephytoparasitolog.]Infectious DiseasesData Interpretation StatisticalLiver biopsyglecaprevir/pibrentasvirHCVDrug Therapy CombinationFemale030211 gastroenterology & hepatologycompensated cirrhosisMicrobiologie et protistologie [parasitologie hum. et anim.]Microbiology (medical)medicine.medical_specialtyGenotypeProlineLactams MacrocyclicHepatitis C virusAntiviral Agents03 medical and health sciencesLeucineQuinoxalinesInternal medicinemedicineHumansAdverse effectAgedbusiness.industryGlecaprevirHepatitis C Chronicmedicine.diseaseBenzimidazolesMicrobiologie et protistologie [bacteriol.virolog.mycolog.]Transient elastographybusinesschronic kidney diseaseKidney diseaseClinical Infectious Diseases
researchProduct

Untersuchungen zur Reaktionsfähigkeit statistisch verteilter Estergruppierungen in Copolymeren aus Styrol und Acrylsäureestern

1974

Die Aminolyse der ortho- und para-Nitrophenylester von Propionsaure, Isobuttersaure, 4-Phenylbuttersaure und 4-Phenylvaleriansaure sowie von Copolymeren aus Styrol und geringen Mengen Acrylsaure wurde mit Butylamin in Dioxan untersucht. Bei grosem Aminuberschus reagieren die niedermolekularen Ester streng nach erster Ordnung, wobei die Reaktionsgeschwindigkeit durch Zugabe von Polystyrol nicht beeinflust wird. Fur Copolymere, deren Reaktionsgeschwindigkeit deutlich geringer ist, erhalt man dagegen keine Beziehung erster Ordnung, obwohl die Anfangsgeschwindigkeit der Gesamtkonzentration der Estergruppen direkt proportional ist. Bei den Copolymeren erhalt man annahernd die gleichen Aktivierun…

Molar massPolymers and PlasticsButylamineMedicinal chemistryStyreneIsobutyric acidchemistry.chemical_compoundColloid and Surface ChemistryPropanoic acidAminolysischemistryPolymer chemistryMaterials ChemistryAmine gas treatingPhysical and Theoretical ChemistryAcrylic acidDie Makromolekulare Chemie
researchProduct

The apparently anomalous effects of surfactants on interfacial tension in the IBA/water system near its upper critical solution temperature

2016

We studied the effect of anionic, cationic, and nonionic surfactants on the interfacial tension between the two phases of the isobutyric acid/water system using spinning drop tensiometry. It has been found that interfacial tension decreases with increasing concentration of the surfactant in the case of sodium dodecyl sulfate (SDS) and of dodecyltrimethylammonium chloride (DTAC). However, in the case of Triton X-100 an increase of surfactant concentration leads to an increase of the interfacial tension. Such results are consistent with the upper critical solution temperature (UCST) in the presence of these surfactants: the UCST decreases with increasing SDS and DTAC concentrations while it i…

Polymers and Plastics02 engineering and technology01 natural sciencesSpinning drop tensiometry010305 fluids & plasmasIsobutyric acidSurface tensionchemistry.chemical_compoundColloid and Surface ChemistryPulmonary surfactantUpper critical solution temperature0103 physical sciencesPolymer chemistryMaterials ChemistryMoleculePhysical and Theoretical ChemistrySodium dodecyl sulfateSettore CHIM/02 - Chimica FisicaChemistryDrop (liquid)Cationic polymerizationUpper critical solution temperature (UCST)021001 nanoscience & nanotechnologyChemical engineering0210 nano-technologyInterfacial tensionColloid and Polymer Science
researchProduct

Evidence for the Existence of an Effective Interfacial Tension between Miscible Fluids: Isobutyric Acid-Water and 1-Butanol-Water in a Spinning-Drop …

2006

We report definitive evidence for an effective interfacial tension between two types of miscible fluids using spinning-drop tensiometry (SDT). Isobutyric acid (IBA) and water have an upper critical solution temperature (UCST) of 26.3 degrees C. We created a drop of the IBA-rich phase in the water-rich phase below the UCST and then increased the temperature above it. Long after the fluids have reached thermal equilibrium, the drop persists. By plotting the inverse of the drop radius cubed (r(-)(3)) vs the rotation rate squared (omega(2)), we confirmed that an interfacial tension exists and estimated its value. The transition between the miscible fluids remained sharp instead of becoming more…

SURFACE-TENSIONThermodynamicsGRADIENTSInstabilityIsobutyric acidSurface tensionchemistry.chemical_compoundNONEQUILIBRIUM FLUCTUATIONS1-ButanolIsobutyratesGRAVITYUpper critical solution temperatureElectrochemistrySurface TensionGeneral Materials ScienceSpectroscopyThermal equilibriumAqueous solutionDrop (liquid)ButanolDIFFUSION-COEFFICIENTWaterSurfaces and InterfacesCondensed Matter PhysicsKORTEWEG STRESSESLIGHT-SCATTERINGCAPILLARY TUBESButyrateschemistrySolubilityLIQUID-MIXTURESSYSTEM
researchProduct

The influence of solvent on conformational properties of peptides with Aib residue—a DFT study

2017

The conformational propensities of the Aib residue on the example of two model peptides Ac-Aib-NHMe (1) and Ac-Aib-NMe2 (2), were studied by B3LYP and M06-2X functionals, in the gas phase and in the polar solvents. To verify the reliability of selected functionals, we also performed MP2 calculations for the tested molecules in vacuum. Polarizable continuum models (PCM and SMD) were used to estimate the solvent effect. Ramachandran maps were calculated to find all energy minima. Noncovalent intramolecular interactions due to hydrogen-bonds and dipole attractions between carbonyl groups are responsible for the relative stabilities of the conformers. In order to verify the theoretical results,…

Solvent effect010402 general chemistryDFT calculations01 natural sciencesCatalysisα-Aminoisobutyric acid residueInorganic ChemistryPolarizabilityMoleculePhysics::Chemical PhysicsPhysical and Theoretical ChemistryConformational isomerismX-ray crystallographyQuantitative Biology::BiomoleculesOriginal Paper010405 organic chemistryHydrogen bondChemistryOrganic ChemistryN-methylation0104 chemical sciencesComputer Science ApplicationsSolventCrystallographyConformational analysisComputational Theory and MathematicsIntramolecular forceSolvent effectsRamachandran plotJournal of Molecular Modeling
researchProduct

Effect of Temperature on Isobutyric Acid Loss during Roasting of Carob Kibble

1997

The high content of isobutyric acid in carob (Ceratonia siliqua L.) constitutes a handicap for some of its potential uses due to the undesirable smell produced by that compound. In this study the loss of isobutyric acid during roasting was approached by heating the carob kibble at temperatures from 120 to 180 °C in two local cultivars (Matalafera and Lisa). The initial content of isobutyric acid varied between 6.3 (Lisa) and 9.4 (Matalafera) g isobutyric acid/kg dry solid. Results showed that the process can be described by a diffusive model. The activation energy of the process is about 55 kJ/mol for both cultivars. Keywords: Carob pod; roasting; isobutyric acid; diffusion

chemistry.chemical_compoundCeratonia siliquafoodChemistryDiffusionBotanyGeneral ChemistryActivation energyFood scienceGeneral Agricultural and Biological Sciencesfood.foodIsobutyric acidRoastingJournal of Agricultural and Food Chemistry
researchProduct